Although the prevalence is only 1% to 6% in the overall hypertensive patients, it is a potentially curable cause of arterial hypertension and ischemic kidney failure.
Aunque la prevalencia es de sólo del 1% al 6% en los pacientes hipertensos, es una causa posiblemente curable de HAS e insuficiencia renal isquémica.